Hope or hype—cytokine therapy in ERCP-induced pancreatitis


In a single-center study from Belgium, Deviere et al. reported the use of the anti-inflammatory cytokine interleukin (IL) 10 as prophylaxis against ERCP-induced pancreatitis. One hundred forty-four patients undergoing ERCP were randomized to receive either a placebo (group 0) or a single i.v. injection of 4 μg/kg (group 1) or 20 μg/kg (group 2) of IL-10 in… (More)
DOI: 10.1111/j.1572-0241.2001.03898.x